logo
Europe wants seamless international train travel. Deutsche Bahn says it's getting there

Europe wants seamless international train travel. Deutsche Bahn says it's getting there

Yahoo28-05-2025
This autumn, Deutsche Bahn (DB), Germany's national railway company, will begin rolling out a new digital infrastructure that it says will streamline international rail bookings.
The move is part of a long-awaited push to simplify travel across Europe's patchwork of national railway networks.
'[You will] be able to book an international journey just as easily as a domestic one,' Michael Peterson, DB's board member for long-distance transport, told German press agency DPA.
'This brings us closer to a major goal,' he continued: seamless cross-border rail travel across Europe, powered by a unified digital system and regulations backed by the EU.
Starting this autumn, DB will adopt a new data-sharing standard known as OSDM (Open Sales and Distribution Model). This EU-endorsed interface is intended to give European rail operators instant access to each other's ticketing systems.
Using the OSDM as a framework, DB says it aims to offer integrated ticketing for virtually all major European railways by the end of 2026, including local transport, through its website and DB Navigator app.
Rail expert Jon Worth is quick to point out that this will not be a single ticket, but rather 'a better way to stitch together tickets from different railways,' however.
DB will initially integrate with Austria and Switzerland's national operators – the ÖBB and SBB, respectively – with other operators to follow in the coming months.
Currently, booking international train tickets through DB's platform can be confusing, limited and, in many cases, expensive.
While passengers can already buy some cross-border tickets running through Germany, many popular routes still require piecing together fares from different companies or making sense of multiple national rail sites. No single rail provider can cover a journey from Berlin to Barcelona, for example.
Aside from convenience, the new system could begin to address a gap in passenger rights.
Currently, travellers using separate tickets for different legs of a cross-border trip risk losing protection if a delay causes a missed connection. Addressing this issue – and ensuring full passenger rights throughout the journey, including rebooking and reimbursement – is such a priority that European Commission President Ursula von der Leyen has made it a cornerstone of her second term.
'Cross-border train travel is still too difficult for many citizens,' she wrote in 2024.
'People should be able to use open booking systems to purchase trans-European journeys with several providers, without losing their right to reimbursement or compensatory travel.'
Related
Taking the train can be almost twice as fast as flying for some journeys in France
Journey through the rainforest in luxury on Malaysia's last remaining sleeper train
But such protection isn't yet guaranteed.
Worth says that the OSDM doesn't compel rail operators to sell unified tickets. It also doesn't ensure consistent enforcement of passenger rights.
'What DB is doing is welcome for Germany, in particular, but it is insufficient,' he explains.
'To get genuine portals on which you can book any train anywhere in Europe, we need more than a technical standard – which is what DB is implementing, essentially – but [rather] binding rules for data sharing, commissions for ticket re-sale and better passenger rights if something goes wrong in a multi-operator rail journey.'
The initiative comes amid increasing pressure from Brussels.
EU Transport Commissioner Apostolos Tzitzikostas has said he plans to propose legislation to create unified platforms and make full passenger rights mandatory.
That's causing some concern for DB – 'already one of the best' rail operators in Europe, according to Worth.
Related
The European tube: Inside the project to launch a continent-wide rail system
New Madrid-Lisbon high-speed train to cut journey time from 10 hours to three
Peterson warned that a digital standard other than the OSDM could undermine years of investment. 'That costs money, that costs time,' he said.
Despite the lingering challenges, DB is optimistic. The company recently launched a direct high-speed ICE route between Berlin and Paris and plans further expansions.
In 2024, DB also saw a 22 per cent increase in cross-border ticket sales compared to pre-pandemic levels – its best year yet.
Now, with better tools, more collaboration and upcoming legislation, Europe's railways could finally begin to catch up with the expectations of climate-conscious travellers – and deliver on the promise of a truly connected continent.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

EU Awards €1.5M Grant to AIxBlock, With €61.5M More in the Pipeline
EU Awards €1.5M Grant to AIxBlock, With €61.5M More in the Pipeline

Associated Press

time24 minutes ago

  • Associated Press

EU Awards €1.5M Grant to AIxBlock, With €61.5M More in the Pipeline

EU backs AIxBlock's mission to decentralize AI development and automate infrastructure workflows—starting with a €1.5M grant and €61.5M in non-dilutive funding pipeline CALIFORNIA, Aug. 04, 2025 (GLOBE NEWSWIRE) -- In a significant show of institutional support, AIxBlock, a decentralized AI tech startup in the Bay Area, has secured a €1.5 million innovation grant from the European Union, alongside with up to €61.5 million in 2 additional grants pre-approved to support its long-term expansion across Europe. The backing positions AIxBlock as a frontrunner in a fast-emerging category: decentralized, automation-first AI infrastructure. The move signals growing European interest in infrastructure that empowers open, decentralized, community-driven platforms—not just hyperscalers—to play a leading role in the AI ecosystem. A Regulatory-Ready Alternative to Centralized AI Infrastructure AIxBlock's €1.5M secured grant comes with zero dilution (with onboarding (KYC) underway prior to fund disbursement), allowing the company to deepen its technology footprint in the EU while preserving ownership and control. The €61.5M in pre-approved funding of 2 other grants will include support for building a physical decentralized GPU network, leveraging underutilized data centers in the region to offer scalable, eco-aligned compute infrastructure in future phases. What AIxBlock Builds AIxBlock is a full-stack platform for end-to-end AI development and workflow automation. It allows startups, agencies, and enterprises to: The platform is designed to give builders full ownership of their infrastructure stack—without vendor lock-in—and to make AI development and automation more affordable, modular, and decentralized. Open Source with Long-Term Contributor Incentives AIxBlock is built with an open-source foundation and invites the global developer and AI community to contribute. Those who participate in improving the platform—whether through code, infrastructure, validation, or ecosystem support—will be eligible for long-term revenue and benefit sharing, proportionate to the value and level of their contribution. This model ensures that core contributors, infrastructure providers, and validators are aligned with the platform's long-term success, with transparent tracking of input and rewards over time. Blockchain as a Coordination and Incentive Layer Blockchain technology plays a critical role in AIxBlock's architecture, serving as the underlying layer for transparency, incentive distribution, and coordination across its decentralized ecosystem. It powers: Scaling Through EU Infrastructure, Responsibly A key part of AIxBlock's roadmap involves tapping into the EU's large base of underutilized data centers to deploy its decentralized GPU network. This expansion is planned for future phases supported by the broader grant pipeline, reflecting a strategy rooted in efficiency, sustainability, and digital sovereignty. By revitalizing existing infrastructure rather than building from scratch, AIxBlock aims to deliver scalable compute capacity while minimizing both environmental impact and geopolitical dependence. Quiet Execution, Long-Term Vision Without any paid marketing since MVP, AIxBlock has already onboarded over 12,000 users organically and secured some enterprise clients who are deploying large-scale model development workflows on the platform. The team continues to focus on expanding core capabilities and preparing for the next wave of infrastructure activation across the EU. As regulators, enterprises, and builders begin to question the scalability and transparency of centralized AI pipelines, platforms like AIxBlock offer an emerging alternative—designed for compliance, customization, and control. Strategic Positioning for Market Leadership With EU support secured and a substantial funding pipeline in place, AIxBlock has built both the credibility and resources to scale with confidence. Its ability to win institutional grants—combined with growing demand for decentralized infrastructure—makes it a compelling partner for strategic investors and ecosystem collaborators. The convergence of AI infrastructure demand and decentralized technology adoption presents a generational opportunity. EU backing provides the regulatory confidence that institutional investors and enterprise clients increasingly seek when evaluating infrastructure plays. As the decentralized AI landscape matures, platforms with public-sector backing, proven technology, and execution capital will be best positioned to lead. AIxBlock's current standing—anchored by confirmed funding, a pre-approved pipeline, and a clear expansion roadmap—signals its emergence as a serious contender in the global AI infrastructure race. Building the AI Operating Layer for Europe With institutional trust, a clear multi-stage public funding pipeline, and a differentiated approach to AI infrastructure, AIxBlock is positioning itself as a critical operating layer for the next era of enterprise and open-source AI development. At a time when developers are demanding more freedom, privacy regulations are tightening, and the cost of compute is rising, AIxBlock offers a new model: Decentralize the resources. Automate the workflows. Reward the community. Build locally, scale globally. About AIxBlock AIxBlock is a next-generation AI infrastructure platform built for developers, startups, and enterprises to build, fine-tune, and deploy AI models with unmatched flexibility and cost efficiency. Combining decentralized GPU resources, end-to-end AI development tools, and workflow automation, AIxBlock eliminates vendor lock-in and reduces compute costs by up to 90%. The platform offers a full-stack, automation-first environment—from data collection and labeling to model training, deployment, and integration with external apps—powered by a decentralized marketplace of models and compute providers. With institutional funding from the European Union (€1.5M Secured) and a roadmap to activate €61.5M more in non-dilutive grants, AIxBlock is building the AI operating layer for Europe and beyond. Website | X | Telegram Contact: Lee Ng [email protected] Disclaimer: This content is provided by AIxBlock. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. We do not guarantee any claims, statements, or promises made in this article. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing in crypto and mining-related opportunities involves significant risks, including the potential loss of capital. It is possible to lose all your capital. These products may not be suitable for everyone, and you should ensure that you understand the risks involved. Seek independent advice if necessary. Speculate only with funds that you can afford to lose. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page. Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. Photos accompanying this announcement are available at:

Bitcoin Mining With Nuclear Energy? French Lawmakers Are Considering It
Bitcoin Mining With Nuclear Energy? French Lawmakers Are Considering It

Yahoo

time43 minutes ago

  • Yahoo

Bitcoin Mining With Nuclear Energy? French Lawmakers Are Considering It

France's far-right political bloc is pushing an ambitious plan to mine Bitcoin (CRYPTO: BTC) using excess energy generated by the country's nuclear power plants. What Happened: The initiative, led by Rassemblement National (RN) lawmakers, marks a striking turn from the party's prior hostility toward cryptocurrencies, and signals a broader ideological shift within European digital asset politics, according to a local news report published on July 30. During a March visit to the Flamanville nuclear facility, party leader Marine Le Pen endorsed the idea of using surplus electricity to power Bitcoin mining operations. The plan would place high-performance computing rigs directly at nuclear sites, converting idle energy into freshly minted Bitcoin, now valued at over €100,000 each. "This is a secure and highly profitable solution," said RN lawmaker Aurélien Lopez-Liguori, who is currently drafting legislation to bring the concept to parliament. He contrasted the proposal with environmentalist positions, stating, "For the Greens, the best energy is what isn't produced. For us, it's energy that isn't wasted." Also Read: Why It Matters: While this marks RN's most concrete proposal on crypto to date, the party's stance on digital currencies has shifted dramatically over the years, from calls to ban them in 2016 to active promotion in 2025. Despite growing enthusiasm among RN members, internal skepticism persists. Senior party official Jean-Philippe Tanguy expressed concern about relinquishing state control over money, warning against "currency independence"—a direct challenge to Bitcoin's original anti-centralization ethos. The RN's sudden embrace of Bitcoin isn't isolated. Other far-right figures, including Sarah Knafo of the Reconquête! party and conservative politician Eric Ciotti, have also championed Bitcoin, with some even calling for France to build national reserves in the digital currency. They cite leaders like Donald Trump and Nayib Bukele as models for blending nationalism with pro-crypto policies. This alignment has deepened ties between right-wing politicians and French crypto entrepreneurs. Some founders, including Ledger's Eric Larchevêque and Paymium's Pierre Noizat, have publicly appeared at far-right events, especially following security threats involving their families. Their comments have increasingly echoed nationalist rhetoric, criticizing the French welfare state and immigration policies while advocating for a "libertarian revival" in Europe. Meanwhile, crypto industry groups lament the politicization of digital assets in France, which they say has been exacerbated by left-wing disengagement. As mainstream parties remain cautious, often citing environmental risks or criminal misuse, industry voices warn that leaving the debate to the far right risks skewing the public narrative. Read Next: Image: Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Bitcoin Mining With Nuclear Energy? French Lawmakers Are Considering It originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio

Pharma CEOs downplay impact of tariffs amid rising cost concerns
Pharma CEOs downplay impact of tariffs amid rising cost concerns

Yahoo

timean hour ago

  • Yahoo

Pharma CEOs downplay impact of tariffs amid rising cost concerns

Despite analyst warnings of heightened financial risk, pharma CEOs across the US and Europe remain confident that the latest US-EU trade deal and associated tariffs will have limited impact. As per a new deal between the two global economic powerhouses, the EU will pay the US a tariff rate of 15% for pharmaceuticals. Medicines are the largest European exports to the US by value, and the EU accounts for approximately 60% of all pharmaceutical imports to the US. Top-selling drugs such as AbbVie's Humira (adalimumab), MSD's Keytruda (pembrolizumab), and Novo Nordisk's Ozempic (semaglutide), for example, are manufactured in Europe and sent to the US, representing billion-dollar markets. Analysts from GlobalData's Pharma Strategic Intelligence team say that: 'Companies manufacturing pharmaceutical products in Europe will need to anticipate financial exposure when planning launches in the US due to the unfavourable gross to net dynamics, weakened pricing leverage with US payers, and slower commercial uptake as insurers reassess cost effectiveness due to the tariffs.' US President Donald Trump has had a sharp focus on the pharma industry since assuming office. Analysts predict that adding duties to incoming goods will likely elevate costs across the pharmaceutical value chain, ultimately raising drug prices for patients. The policies make for interesting analysis when combined with his desire to cut prescription prices in the country. Diederik Stadig, sector economist for TMT & healthcare at ING, wrote in a July note: 'A tariff would hurt consumers most of all, as they would feel the inflationary effect of tariffs directly when paying for prescriptions.' The European Federation of Pharmaceutical Industries and Associations (EFPIA), for example, has maintained that tariffs on medicines are ineffective. The group says such policies only hinder patient access to medicines. GlobalData also forecasts disruptions to launch planning, particularly late-stage assets with EU-based manufacturing and production planned for entry into the US. R&D budgets of pharmaceutical companies are already under pressure and the firefighting of tariffs could place additional strain on resources. CEOs signal resilience CEOs of big pharma companies, however, are maintaining a brave face despite the projected headwinds. The UK-EU trade deal announcement arrived in the middle of the pharma industry's Q2 reporting period, where execs were pressed on financial outlooks. In a Q2 earnings call, AbbVie's CEO Rob Michael said the US company is 'fairly insulated' from any tariff-related impacts in 2025, though caveated that the company would not speculate on the longer-term consequences. AstraZeneca shared the same sentiment. CEO Pascal Soriot said the British-Swedish drugmaker is 'almost self-sufficient in terms of supply,' adding that 'tariffs is not an issue that is really affecting us very much.' However, AstraZeneca is on a long list of pharma companies transferring manufacturing to the US. This includes a $4bn investment to build a new manufacturing plant in Virginia. Sanofi has outlaid $20bn to bolster US manufacturing through 2030 and Roche unveiled a similar $50bn investment strategy, to name just a couple. The team at GlobalData added: 'Ultimately, the recent US-EU trade deal has increased the level of uncertainty within the pharmaceutical industry, raising concerns on the potential of tariffs increasing past 15% in the future. 'While the full impact will take time to unfold, it will be interesting to see the adoption of different strategies on how the pharmaceutical industry looks to balance innovation, and ensuring patient access, while managing the pressures of tariffs as they unfold into a certain reality.' A critical part of the industry's future also relies on the outcome of the US government's Section 232 investigation into the drug sector. The probe, which Trump initiated to evaluate the role of medicine imports on national security, could result in further tariffs being imposed. MSD CEO Rob Davis said in the company's Q2 earnings call: 'We need to see more clarity both from the administration and just overall as to how exactly [the 15% tariff] is going to play out. It's still not clear exactly how this relates relative to the February investigation and the timing of whether these apply now or will be phased in until there's further guidance.' AbbVie's Michael said: 'We're having constructive discussions with the administration on sectoral tariffs. Clearly, the best way to motivate that is through tax incentives as well as a trade agenda that prioritises innovation. We're well positioned as a company, but we're not going to be able to really give you any details until we understand the outcome of the 232 investigation.' Navigate the shifting tariff landscape with real-time data and market-leading analysis. Request a free demo for GlobalData's Strategic Intelligence . "Pharma CEOs downplay impact of tariffs amid rising cost concerns" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store